SCHEMBL6605400

SCHEMBL6605400

CCOC(CSc1cccc(F)c1)OCC

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 2/20 0.34
PTGER1 P34995 1/20 0.34
PTGFR P43088 1/20 0.34
FFAR1 O14842 1/20 0.34
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EPHX1 P07099 1/20 0.33
ACHE P22303 1/20 0.33
SLC6A9 P48067 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HAO1 Q9UJM8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7214204 0.83 MAOA (0.39) MAOAALDH1A1LMNAL3MBTL1MAOB
SCHEMBL3812917 0.82 MAOA (0.38) MAOAALDH1A1MAOBPTGER1PTGFR
SCHEMBL7867405 0.81 EPHX1 (0.40) MAOALMNAL3MBTL1MAOBEPHX1
SCHEMBL22468935 0.81 BACE1 (0.44) MAOAALDH1A1MAOBMTNR1AMTNR1B
SCHEMBL1868023 0.81 MAOA (0.59) MAOAALDH1A1MAOBMTNR1AMTNR1B
SCHEMBL1777148 0.80 MAPT (0.35) MAOAALDH1A1L3MBTL1MAOBSMN1; SMN2
SCHEMBL228468 0.79 MTNR1A (0.53) MAOAMAOBMTNR1AMTNR1BACHE
SCHEMBL20040647 0.79 TP53 (0.45) MAOAALDH1A1LMNAMAOBMTNR1A
SCHEMBL12135641 0.79 MAOA (0.52) MAOAALDH1A1L3MBTL1MAOBFFAR1
SCHEMBL19740123 0.79 KDM4E (0.34) ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040266826-A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-30 US disclosed
EP-1423386-A1 THIOPHENYLTHIOPYRANE DIOXIDES AS MMP OR TNF-ALPHA INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-02 EP disclosed
WO-2003022842-A1 THIOPHENYLTHIOPYRANE DIOXIDES AS MMP OR TNF-ALPHA INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266826-A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors TNF, MMP9, MMP1 MAOA 1073/4885ALDH1A1 440/4885LMNA 2725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.